Crossmark

Efficacy of fourteen-day once-daily vonoprazan-based quadruple therapy for Helicobacter pylori in high clarithromycin-resistance regions (ONCE-VONO Trial)

Crossref DOI link: https://doi.org/10.1038/s41598-025-27876-z

Published Online: 2025-12-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sukkamolsantiporn, Saran

Bongkotvirawan, Phubordee

Chonprasertsuk, Soonthorn

Pornthisarn, Bubpha

Siramolpiwat, Sith

Bhanthumkomol, Patommatat

Issariyakulkarn, Navapan

Gamnarai, Pornpen

Wongcha-Um, Arti

Aumpan, Natsuda

Vilaichone, Virunpat

Sornchuer, Phornphan

Mahachai, Varocha

Miftahussurur, Muhammad

Yamaoka, Yoshio

Kitipawong, Peerapong

Vilaichone, Ratha-korn
License Information

Text and Data Mining valid from 2025-12-18

Version of Record valid from 2025-12-18
More Information

Article History

Received: 23 July 2025

Accepted: 6 November 2025

First Online: 18 December 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below